# Alpha-Ketoglutarate and Abdominal Aortic Aneurysm Progression and Rupture

> **NCT04723888** · NA · RECRUITING · sponsor: **RenJi Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Patients With an Abdominal Aortic Aneurysm of 39-49 mm in Diameter

## Interventions

- **DIETARY_SUPPLEMENT:** alpha-ketoglutarate

## Key facts

- **NCT ID:** NCT04723888
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-01
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04723888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04723888, "Alpha-Ketoglutarate and Abdominal Aortic Aneurysm Progression and Rupture". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04723888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*